A woman in her early 60s cycles home from the office through light rain. She has worn glasses and contact lenses since she was 19. A burning, gritty sensation has been building under her upper eyelid the past few weeks, coinciding with a move to a new office space. She blinks, rubs her eyes, keeps going. Her last optometry appointment was four months ago. Her next is months away. Between those two dates, her symptoms will fluctuate, worsen on some days, ease on others, and leave behind a trail of clinical data that nobody will collect.

By the time she sits in the examination chair again, what she reports will be a vague reconstruction shaped by whatever happened to be bothering her that morning. For most patients with chronic ocular conditions, this is how care works. The consultation is a snapshot in time. It only tells the clinician what the patient’s eye health is like at that moment, rather than what has changed since last time. The trajectory that actually defines the disease plays out in the long gaps between these snapshot consultations, where nobody is watching. Two areas where this shows up most clearly are contact lens retention and dry eye progression.

The numbers between the chairs

UK research on contact lens retention rates puts the first-year dropout rate among new wearers at roughly one in four. Visual problems, discomfort, dryness, and handling difficulties top the list (1, 2). Most of those who discontinue never try an alternative lens type, or an adjusted wearing regime. They just go back to spectacles.

Meanwhile, dry eye disease remains one of the most diagnosed conditions across optometry and ophthalmology worldwide. It spans screen-dependent children, menopausal women with altered ocular surface chemistry, and older patients on medications that suppress mucous membrane function (3). The international consensus is that it is a chronic, multifactorial disease capable of causing corneal damage and vision loss. Patients, for the most part, treat it as a minor irritation. That mismatch between clinical reality and patient perception delays presentation, undermines adherence, and leaves a large population under-treated.

What links these two problems is that the clinically significant changes are happening outside the practice, and the care model does not reach them there – creating an avoidable gap in patient safety between visits.

A model designed for a different era

Interval-based review was built for a time when gathering patient information between visits was expensive and logistically impractical. A patient attends, provides a verbal account of what they remember, receives an examination, and leaves. In between, perhaps a phone call from a practice assistant. This made sense when it was the only realistic option. In modern healthcare systems – where patient safety is increasingly measured by what is prevented between encounters as much as what is detected during them – this gap becomes more difficult to justify.

Nearly every other area of chronic disease management has begun incorporating continuous patient engagement in some form, whether through remote monitoring, automated follow-up protocols, or digital symptom tracking that feeds back into clinical decision-making. Cardiology and diabetes care have both moved in this direction. Respiratory medicine is doing the same. Eye care, broadly speaking, has not. It's behind the curve, and patients are the ones living with the consequences.

For example, a 32-year-old mechanic switches to contact lenses because his glasses fog up and interfere with safety goggles. Four weeks in, his right eye feels gritty by the afternoon. His vision is slightly off. He has not been back to his optometrist since his fitting. Nobody has asked how he is getting on, and he is unlikely to volunteer the information himself. He is considering giving up on lenses entirely. The discomfort is often addressable with a simple change of lens material or a different wearing schedule, sometimes just targeted lubrication (4). But the window to intervene passes without anyone knowing there was a window at all.

There is another dimension to this. Continuous monitoring does not just reach patients earlier; it removes the need for precautionary appointments that add no clinical value. When a patient is stable and their symptom data shows no change, the system can confirm that review can wait. When a patient is deteriorating, it can trigger a visit before harm occurs. Care becomes responsive to clinical needs rather than driven by the calendar.

For dry eye patients, the pattern is slower but no less consequential. Symptom fluctuation with environment, season, screen exposure, and medication makes a single annual data point a poor basis for treatment decisions. Evidence-based guidelines still lack robust frameworks for adjusting therapy based on continuous symptom data (5). That gap is partly a data collection problem. We have not had the infrastructure to track what happens between visits, so our treatment models have been built without it.

Closing the gap

The point of digital follow-up is not to replace the consultation. It is to change what the clinician has in front of them before the patient walks in, and to reach the patient while the intervention can still make a difference.

In practice, it looks like this: The woman with worsening dry eyes receives a brief check-in on her phone one evening, a few structured questions from her optometrist's practice. She completes them while making tea. The system registers increasing discomfort and flags her clinician. The next morning, she gets a message acknowledging the change and offering a call or appointment. Her dry eye is now part of a monitored trajectory, rather than an isolated measurement taken twice a year.

For the mechanic, a similar check-in at week three picks up afternoon dryness and visual discomfort. He receives a tailored guide explaining what those symptoms typically indicate, what he can try at home, and when to come in. If the problem persists, an appointment is triggered automatically. He stays in the system instead of drifting out of it.

The consultation itself changes too. When each appointment begins with weeks or months of structured symptom data, the clinician's starting point is a pattern, not a patient's best recollection. Deteriorations and improvements become visible when they are actionable. Treatment adjustments can be more responsive, more personalized, and better timed. Those are gains for individual patients, but the effects compound when you apply this across a whole practice or patient population.

What continuous follow-up means at scale

Patient safety rankings increasingly reflect not just what happens in the clinic, but what happens between visits. Countries that perform well, such as Norway, have recognized that continuity of monitoring is itself a safety intervention.

Contact lens wearers who are drifting toward dropout get reached in the critical early weeks, not at a six-month review that arrives too late. Dry eye patients whose symptoms are escalating receive earlier intervention, potentially avoiding the complications that require more intensive treatment downstream. Patients who feel their care extends beyond the appointment room have less reason to disengage from the practice, and more reason to follow through on treatment.

Across a population, earlier intervention means fewer complications. Better retention means fewer lost patients. And continuous data, collected across cohorts, starts to surface patterns that fixed-interval consultations will never pick up.

The technology to support this already exists. Digital follow-up platforms can sit alongside existing patient management systems, running pre-visit questionnaires, automated symptom check-ins, clinician alerts, and tailored patient communication with minimal administrative overhead for the practice. Dry eye monitoring and contact lens retention pathways are among the most developed applications, and early deployments in partnership with major optical chains are already underway in Europe.

So, what does this look like for the patient?

Care that follows you home

The woman on her bicycle is nearly home. The rain has stopped, and thin sunlight is breaking through above the canal. In her jacket pocket, her phone holds a notification she hasn't opened yet. It is asking how her eyes have been today. 

For her and millions of other patients living with chronic eye conditions, it is a few questions on a screen. But it is also what eye care starts to look like when someone is paying attention between the visits. The tools exist, and it is time we used them to close a preventable gap in patient safety between visits.